Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, typically developing slowly over time. Early symptoms may include painless lumps or swelling under the skin ...

Hematopoietic stem cell transplantation (HSCT) use in CLL decreased by 42% from 2009 to 2018 due to new treatment options. Non-relapse mortality (NRM) improved significantly, attributed to ...

AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...

This caspase-independent death pathway may be relevant to the development of alternate therapeutic strategies in chronic lymphocytic leukemia, which remains an incurable disease. Here, we ...

It is estimated that more than 5 million people worldwide suffer from ulcerative colitis, a chronic inflammation of the colon that often progresses in stages whose causes have not yet been fully ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial.

A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by today's most popular opioids. The drug also sidesteps common opioid side ...

Diagnosed with chronic T-cell LGL at 31, the author faced initial disbelief from doctors and a challenging prognosis. Despite numerous treatments, the focus shifted from survival to quality of life, ...

Defects in the DNA damage sensors, particularly in the ataxia telengiectasia mutated (ATM)/TP53 pathways, confer resistance to standard chemotherapic agents used in CLL [4] that inflict DNA damage ...

This week, the Supreme Court continued to deliberate over what to do with the growing number of national or universal injunctions issued by federal district courts against the Trump Administration ...